NCT01965912 - Kuvan®'s Effect on the Cognition of Children With Phenylketonuria | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 4, 2023

Study Completion Date

January 4, 2023

Conditions

Phenylketonuria

Interventions

DRUG

Kuvan®

Kuvan® oral soluble tablet will be administered once daily along with Phenylalanine-restricted diet for a period of 7 years. Dosage of Kuvan® could range from 5 to 20 milligram per kilogram per day (mg/kg/day), as per Summary of Product Characteristics (SPC).

Trial Locations (12)

Unknown

Research site, Munich

Research site, Münster

Research site, Bologna

Research site - Bambino Gesu, Roma

Research site - La Sapienza, Roma

Research Site, Barcelona

Research site, Murcia

Research site, Santiago de Compostela

Research site, Birmingham

Research site, Bristol

Research Site - Evelina, London

Research site - GOSH, London